Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study

Completed · Phase 3 · Has a placebo group

Conditions studied: Alzheimer's Disease

In brief

This study seeks to confirm a demonstrated treatment effect of intepirdine (RVT-101) as an adjunctive therapy to donepezil for the treatment of subjects with Alzheimer's disease.

Key facts

Study ID

NCT02585934

Run by

Axovant Sciences Ltd.

People needed

1315

Starts

2015-10-01

Expected to finish

2017-09-01

Last updated by the study team

2018-12-05

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subject with AD
• Ongoing donepezil therapy for AD
• An MMSE score 12 to 24 inclusive at Screening; MMSE score 10-26 inclusive at Baseline
• Hachinski Ischaemia score less than or equal to 4 at Screening.
• If female, subject must be: a. of non-childbearing potential or surgically sterile; or, b. willing to use an adequate methods of birth control. Male subjects who are sexually active will also be required to use an adequate form of birth control.
• Subject has the ability to comply with procedures for cognitive and other testing in the opinion of the investigator.
• Subject has a reliable caregiver who is willing to report on subject's status throughout the study.

You may not qualify if…

• Other Causes for Dementia
• Diagnosis of vascular dementia
• Atypical clinical features or clinical course of dementia that would lead the investigator to conclude symptoms are more likely due to an alternate dementia diagnosis including, but not limited to, frontotemporal dementia, Lewy body dementia, or others.
• Confounding Medical Conditions
• History of significant psychiatric illness such as schizophrenia or bipolar affective disorder or any other significant psychiatric illness that in the opinion of the investigator would interfere with participation in the study;
• Any clinically relevant concomitant disease, which, in the opinion of the investigator, makes the subject unsuitable for inclusion in the study.

Where it is running

• US220 — Tucson, Arizona, United States
• US168 — Encino, California, United States
• US117 — Fullerton, California, United States
• US214 — Los Angeles, California, United States
• US189 — Pasadena, California, United States
• US096 — Rancho Mirage, California, United States
• US0195 — Santa Ana, California, United States
• US016 — Simi Valley, California, United States
• US106 — Temecula, California, United States
• US179 — Hamden, Connecticut, United States
• US171 — Norwich, Connecticut, United States
• US088 — Atlantis, Florida, United States
• US007 — Brooksville, Florida, United States
• US002 — Hallandale, Florida, United States
• US140 — Hialeah, Florida, United States
• US216 — Miami, Florida, United States
• US110 — Miami, Florida, United States
• US172 — North Palm Beach, Florida, United States
• US003 — Orlando, Florida, United States
• US256 — Pensacola, Florida, United States
• US037 — Tampa, Florida, United States
• US042 — Tampa, Florida, United States
• US004 — The Villages, Florida, United States
• US048 — Atlanta, Georgia, United States
• US112 — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.